Introduction The incidence of breast cancer ranks the first in female malignancy with an increasing trend ( 1 - 3 ).
← all excerpts
Efficacy, cardiotoxicity and factors affecting pathologic complete response of neoadjuvant chemotherapy with anthracycline-containing verses anthracycline-free regimens plus dual HER2 blockade for HER2-positive early-stage breast cancer: a retrospective study.
1
—
—